These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6373003)

  • 1. Decreased stabilization of prostacyclin activity in patients with bone tumors.
    Mehta P; Ostrowski N; Brigmon L
    Cancer Res; 1984 Jul; 44(7):3132-4. PubMed ID: 6373003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors.
    Mehta P; Gross S; Ostrowski N
    Am J Pediatr Hematol Oncol; 1985; 7(1):88-91. PubMed ID: 2994511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood serum somatomedin activity in children with bone tumors].
    Vasil'eva IA; Ionov AA; Borodina AF
    Vopr Onkol; 1982; 28(7):38-41. PubMed ID: 6954761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologic activity of prostacyclin in patients with malignant tumors of the bones and soft tissues].
    Tucci A; del Prete S; Maione C
    Medicina (Firenze); 1989; 9(2):187-9. PubMed ID: 2509850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble p185(HER-2) in patients with malignant bone tumours.
    Holzer G; Pfandlsteiner T; Koschat M; Noske H; Trieb K; Kotz R
    Pediatr Blood Cancer; 2005 Feb; 44(2):163-6. PubMed ID: 15468309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumours.
    Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
    Anticancer Res; 2003; 23(3C):3057-9. PubMed ID: 12926161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum isoenzymes of lactate dehydrogenase, esterase and alkaline phosphatase in several bone tumors].
    Surinov BP; Menzhinskaia GV
    Vopr Onkol; 1975; 21(5):23-6. PubMed ID: 1108434
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum protein and immunoglobulin profile in Ewing's sarcoma of bone--a preliminary study.
    Gupta RM; Verma BP; Gupta IM
    Indian J Pathol Microbiol; 1976 Jul; 19(3):147-50. PubMed ID: 992861
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and haematological findings in malignant bone tumours.
    Brozmanová E; SKROVINA B
    Neoplasma; 1974; 21(1):75-82. PubMed ID: 4522900
    [No Abstract]   [Full Text] [Related]  

  • 12. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various prognostic factors in the radiotherapy and chemoradiotherapy of Ewing's sarcoma].
    Sokolova II; Kuznetsova IP; Mel'nikova RN
    Sov Med; 1983; (12):26-30. PubMed ID: 6673140
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors.
    Svoboda M; Thalhammer T; Aust S; Arrich F; Assadian O; Toma CD
    J Surg Oncol; 2007 Jun; 95(7):572-81. PubMed ID: 17230544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of polychemotherapy in the management of malignant bone tumors].
    Reichardt P; Dörken B
    Chirurg; 2002 Dec; 73(12):1170-3. PubMed ID: 12491045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.
    Menter DG; Harkins C; Onoda J; Riorden W; Sloane BF; Taylor JD; Honn KV
    Invasion Metastasis; 1987; 7(2):109-28. PubMed ID: 3294727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-immunological studies of 32 cases of bone tumors].
    Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
    Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: a Scandinavian sarcoma group study.
    Aksnes LH; Bauer HC; Dahl AA; Fosså SD; Hjorth L; Jebsen N; Lernedal H; Hall KS
    Pediatr Blood Cancer; 2009 Jul; 53(1):84-9. PubMed ID: 19343771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin and platelet aggregation in sickle cell disease.
    Mehta P; Albiol L
    Pediatrics; 1982 Sep; 70(3):354-9. PubMed ID: 6896748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.